Where can I listen to this podcast?

This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

Yes, this podcast regularly features guests.

scientifica sessions.

Claim This Podcast

by Tabari Baker

5.0(1 reviews)

10 episodes

Updated Daily

Accepts GuestsHas SponsorsLocation 🇺🇸

Podcast Overview

Hosted by Tabari Baker, CEO of kronos scientifica, scientifica sessions features unscripted conversations with the executives, innovators, and visionaries shaping the future of biotech, medtech, pharma, and healthtech. Each episode dives into the realities of leadership in a rapidly evolving industry: scaling medical affairs and commercial teams, building investor confidence, navigating regulatory shifts, unlocking digital health and AI, and driving commercialization strategies that matter. Guests share candid stories from the boardroom to the clinic—what worked, what didn't, and what's next. If you're a CEO, CMO, commercial leader, investor, or startup founder, scientifica sessions gives you insider access to the lessons, strategies, and perspectives that don't show up in press releases or pitch decks.

Language

🇺🇲

Publishing Since

9/14/2025

Visit Website View on Apple Podcasts RSS Feed

2 verified contact emails on file for scientifica sessions.

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

See contact details

Recent Episodes

May 28, 2026

Southern Catalyst: How Atlanta Is Building the Southeast’s Life Sciences Powerhouse

Episode Description:Atlanta is often overlooked in the life sciences conversation—but what if that's exactly the point?In this episode of scientifica sessions, we go inside the Atlanta ecosystem to unpack how a city built on public health leadership, world-class institutions, and deep clinical infrastructure is quietly assembling one of the most strategically compelling life sciences hubs in the United States.Atlanta isn't trying to be Boston or San Diego. It's building something distinctly its own: a scale-up hub rooted in the interplay of the CDC, Emory University, Georgia Tech, a massive and diverse patient population, the world's busiest airport, and a collaboration culture that most markets can't manufacture.We explore how Atlanta is:<ul><li>Defining its identity as a scale-up hub through Georgia's first-ever life sciences roadmap</li><li>Attracting global companies like UCB to site U.S. manufacturing in the Southeast</li><li>Building bio-literacy through K-12 programs that have reached over 270,000 students statewide</li><li>Developing clinical infrastructure—including Children's Healthcare of Atlanta, home to more pediatric clinical trial beds than any U.S. children's hospital system</li><li>Navigating the capital gap through government funding, foundations, and a maturing local venture ecosystem</li></ul>The conversation also confronts the valley of death head-on—what it actually looks like when a company survives it through disciplined decision-making, capital efficiency, and the courage to move slowly when everything says move fast.What We Covered:<ul><li>Why assets alone don't create a hub—and what the interplay looks like in Atlanta</li><li>How Atlanta's distributed micro-hub structure creates both opportunity and challenge</li><li>The real estate decisions that kill companies—and the discipline required to avoid them</li><li>Why Atlanta's quality of life and cost structure are becoming a structural competitive advantage</li><li>How Georgia's first life sciences roadmap is shaping the ecosystem's next decade</li></ul>Takeaway: Atlanta didn't stumble into this moment. It built toward it for twenty years. The decade of intentionality starts now.Connect with the guests 🔗 LinkedIn: <a rel="noopener noreferrer nofollow" href="https://www.linkedin.com/in/mariathacker/" target="_blank">Maria Thacker Goethe</a>; <a rel="noopener noreferrer nofollow" href="https://www.linkedin.com/in/steven-damon-a1966a5/" target="_blank">Steven Damon</a>; <a rel="noopener noreferrer nofollow" href="https://www.linkedin.com/in/jburns301/" target="_blank">Justin Burns, Ph.D.</a>; <a rel="noopener noreferrer nofollow" href="https://www.linkedin.com/in/andy-roberts-cresa-atl/" target="_blank">Andy Roberts</a>📩 Connect with the show: <a rel="noopener noreferrer nofollow" href="mailto:podcast@kronosscientifica.com" target="_blank">podcast@kronosscientifica.com</a>Produced by <a rel="noopener noreferrer nofollow" href="https://www.linkedin.com/company/thread-tensor/" target="_blank">Thread and Tensor</a>.

April 7, 2026

Cracking the Code: How Massachusetts Built the Most Intentional Life Sciences Ecosystem in the World

Episode Description:Massachusetts is often viewed as the epicenter of biotech—but what actually makes this ecosystem work?In this episode of scientifica sessions, we go inside the Commonwealth to unpack the deliberate strategy behind one of the most successful life sciences hubs in the world. Joined by leaders from the Massachusetts Life Sciences Center (MLSC) and founders building within the ecosystem, this conversation moves beyond Kendall Square to reveal a statewide model designed for scale, inclusion, and long-term impact.At the center of it all is MLSC—a quasi-public engine deploying capital, building infrastructure, and shaping policy to ensure innovation doesn’t just start in Massachusetts, but stays and grows there.We explore how Massachusetts has:<ul><li>Built a true public-private partnership across government, academia, and industry</li><li>Used non-dilutive funding to de-risk early innovation and unlock venture capital</li><li>Created intentional pathways for underrepresented founders through programs like Mass Next Gen</li><li>Expanded beyond Boston to develop thriving clusters across the entire Commonwealth</li><li>Leveraged density—not just of capital, but of experience, mentorship, and talent—to accelerate company growth</li></ul>The conversation also dives into one of the most critical challenges in biotech—the “valley of death”—and how Massachusetts is actively building systems to help companies transition from early discovery to viable, revenue-generating businesses.What emerges is a blueprint: an ecosystem that listens, evolves, and invests with purpose—across talent, infrastructure, capital, and community.If you’re building, investing, or thinking about how to scale innovation in life sciences, this episode offers a rare look at what it takes to get it right.What We Covered:<ul><li>The four pillars of a successful life sciences hub.</li><li>Why non-dilutive funding is more than capital—it’s protection and development.</li><li>How MLSC designs programs based on real ecosystem gaps.</li><li>The role of density in mentorship, talent, and commercialization.</li><li>Why the future of biotech ecosystems is statewide—not city-bound.</li></ul>Takeaway: Massachusetts didn’t become a global leader by chance—it built an intentional system to make innovation inevitable.Connect with the guests 🔗 LinkedIn: <a rel="noopener noreferrer nofollow" href="https://www.linkedin.com/in/tiffanymrich/" target="_blank">Tiffany Walther, PhD;</a><a rel="noopener noreferrer nofollow" href="https://www.linkedin.com/in/kelley-dowd-ph-d-398705b8/" target="_blank"> </a><a rel="noopener noreferrer nofollow" href="https://www.linkedin.com/in/samantha-johnson-7001b413a/" target="_blank">Samantha Johnson; </a><a rel="noopener noreferrer nofollow" href="https://www.linkedin.com/in/kelley-dowd-ph-d-398705b8/" target="_blank"> </a><a rel="noopener noreferrer nofollow" href="https://www.linkedin.com/in/minmin-yen/" target="_blank">Minmin (Mimi) Yen, PhD, MPH; </a><a rel="noopener noreferrer nofollow" href="https://www.linkedin.com/in/asmi-chakraborty-cancerbiology/" target="_blank">Asmi Chakraborty, PhD</a><a rel="noopener noreferrer nofollow" href="https://www.linkedin.com/in/kelley-dowd-ph-d-398705b8/" target="_blank">; </a><a rel="noopener noreferrer nofollow" href="https://www.linkedin.com/in/ryan-mudawar/" target="_blank">Ryan Mudawar</a>📩 Connect with the show: podcast@kronosscientifica.comProduced by <a rel="noopener noreferrer nofollow" href="https://www.linkedin.com/company/thread-tensor/" target="_blank">Thread and Tensor</a>.

February 16, 2026

The Frontier Formula: Oklahoma's Blueprint for America's Next Life Sciences Hub

Episode DescriptionWhat if the next great American life sciences hub isn’t on the coasts—but in the heartland?In this episode of scientifica sessions, we look beyond the usual biotech strongholds to explore Oklahoma’s emergence as a new life sciences contender. While Boston and San Francisco dominate the narrative, Oklahoma is quietly building a different model—one that blends energy-sector expertise, agricultural biotechnology, and targeted infrastructure investment to create a distinct innovation advantage.Host Tabari Baker is joined by Oklahoma life sciences leaders:<ul><li>Carol Curtis, PhD</li><li>Nicholete Davis</li><li>Kelley Dowd, PhD</li><li>Madison Jackson</li><li>Patrick Lucy</li></ul>Together, they unpack what it really takes to build a life sciences ecosystem from the ground up. This isn’t a generic “emerging hub” story—it’s a candid look at convergent innovation, where energy capital fuels therapeutic development, and regional strengths shape a new path forward.In this episode, you’ll learn:<ul><li>Why Oklahoma’s “late start” may actually be a competitive advantage.</li><li>How energy-industry capital and operational discipline are being repurposed for biotech.</li><li>The infrastructure gaps that could accelerate—or constrain—ecosystem growth.</li><li>What funding models are emerging before traditional venture capital arrives.</li><li>How Oklahoma is addressing talent development without an established biotech workforce.</li><li>The unique role of Native American healthcare systems in advancing innovation.</li></ul>Key segments include:<ul><li>The Anatomy of a Hub: Foundational assets and authentic differentiators.</li><li>Capital and Commercialization: Creative funding approaches and early success stories.</li><li>Infrastructure and Place: Lab space, cost structure, and quality-of-life advantages.</li><li>Talent Flywheels: Workforce pipelines and entrepreneurial culture building.</li></ul>Whether you’re an entrepreneur deciding where to launch, an investor searching for untapped opportunity, or a life sciences leader tracking how innovation geography is shifting, this episode offers actionable insight into one of biotechnology’s most compelling frontier markets.Connect with the guests 🔗 LinkedIn: <a rel="noopener noreferrer nofollow" href="https://www.linkedin.com/in/kelley-dowd-ph-d-398705b8/" target="_blank">Kelley Dowd</a><a rel="noopener noreferrer nofollow" href="https://www.linkedin.com/in/dangoddard77/" target="_blank">, </a><a rel="noopener noreferrer nofollow" href="https://www.linkedin.com/in/nicholete-davis/" target="_blank">Nicholete Davis</a><a rel="noopener noreferrer nofollow" href="https://www.linkedin.com/in/dangoddard77/" target="_blank">, </a><a rel="noopener noreferrer nofollow" href="https://www.linkedin.com/in/patricklucy/" target="_blank">Patrick Lucy</a><a rel="noopener noreferrer nofollow" href="https://www.linkedin.com/in/dangoddard77/" target="_blank">, </a><a rel="noopener noreferrer nofollow" href="https://www.linkedin.com/in/carol-curtis-phd/" target="_blank">Carol Curtis</a><a rel="noopener noreferrer nofollow" href="https://www.linkedin.com/in/dangoddard77/" target="_blank">, </a><a rel="noopener noreferrer nofollow" href="https://www.linkedin.com/in/madisonljackson/" target="_blank">Madison Jackson</a>📩 Connect with the show: podcast@kronosscientifica.comProduced by <a rel="noopener noreferrer nofollow" href="https://www.linkedin.com/company/thread-tensor/" target="_blank">Thread and Tensor</a>.

10 total episodes available

Deep-dive analytics for scientifica sessions.

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is scientifica sessions.?: Hosted by Tabari Baker, CEO of kronos scientifica, scientifica sessions features unscripted conversations with the executives, innovators, and visionaries shaping the future of biotech, medtech, pharma, and healthtech.

Each episode dives into the realities of leadership in a rapidly evolving industry: scaling medical affairs and commercial teams, building investor confidence, navigating regulatory shifts, unlocking digital health and AI, and driving commercialization strategies that matter. Guests share candid stories from the boardroom to the clinic—what worked, what didn't, and what's next.

If you're a CEO, CMO, commercial leader, investor, or startup founder, scientifica sessions gives you insider access to the lessons, strategies, and perspectives that don't show up in press releases or pitch decks.
How often does this podcast release new episodes?: This podcast updates daily.
Where can I listen to this podcast?: This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
Does this podcast accept guests?: Yes, this podcast regularly features guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.